This trial compares a new investigational drug, a biosimilar, with an existing drug currently approved for the treatment of severe psoriasis, psoriatic arthritis, plaque psoriasis and Crohn’s disease patients. The new medication aims to be a more affordable option for people living with these conditions.
For this trial we need the help of male participants, or female participants who are not pregnant or breastfeeding, aged from 18 to 55 (inclusive) who are in good health and are light or non-smokers and do not have a history of alcohol abuse or drug addiction. This trial will enrol up to 210 participants.
If you meet the criteria for this study and would like more information, register below or call 1800 727 874.